drugset / Trial / NCT06026917
Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)
NaSingle-groupOpen-labelTreatment
Summary
This study was a single-arm, open-label clinical study to assess dopamine transporter occupancy in the brain of patients with depression using 11C-CFT positron emission tomography (PET).
Timeline
- Start
- 2023-09-25
- Primary completion
- 2024-01-31
- Completion
- 2024-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Toludesvenlafaxine | Small molecule | 80 mg | — |
| Subject | Toludesvenlafaxine | Small molecule | 160 mg | — |